BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8428691)

  • 1. Studies on ras oncogene activation in endometrial carcinoma.
    Fujimoto I; Shimizu Y; Hirai Y; Chen JT; Teshima H; Hasumi K; Masubuchi K; Takahashi M
    Gynecol Oncol; 1993 Feb; 48(2):196-202. PubMed ID: 8428691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. K-ras point mutations in endometrial carcinoma: effect on outcome is dependent on age of patient.
    Ito K; Watanabe K; Nasim S; Sasano H; Sato S; Yajima A; Silverberg SG; Garrett CT
    Gynecol Oncol; 1996 Nov; 63(2):238-46. PubMed ID: 8910634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early mutational activation of the c-Ki-ras oncogene in endometrial carcinoma.
    Duggan BD; Felix JC; Muderspach LI; Tsao JL; Shibata DK
    Cancer Res; 1994 Mar; 54(6):1604-7. PubMed ID: 8137266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. K-ras activation in premalignant and malignant epithelial lesions of the human uterus.
    Enomoto T; Inoue M; Perantoni AO; Buzard GS; Miki H; Tanizawa O; Rice JM
    Cancer Res; 1991 Oct; 51(19):5308-14. PubMed ID: 1913654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on the point mutation of ras oncogene in ovarian tumor].
    Fujimoto I; Shimizu Y; Umezawa S; Katase K; Hirai Y; Yamauchi K; Hasumi K
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Nov; 45(11):1289-96. PubMed ID: 8258728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. K-ras activation in neoplasms of the human female reproductive tract.
    Enomoto T; Inoue M; Perantoni AO; Terakawa N; Tanizawa O; Rice JM
    Cancer Res; 1990 Oct; 50(19):6139-45. PubMed ID: 2205377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
    Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H
    Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection of K-ras oncogene activation in human lung cancer and its possible clinical application].
    Zhang G; Sun Y; Wang M
    Zhonghua Jie He He Hu Xi Za Zhi; 1995 Oct; 18(5):282-4, 317. PubMed ID: 8762479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ras gene mutations as a prognostic marker in adenocarcinoma of the human lung without lymph node metastasis.
    Sugio K; Ishida T; Yokoyama H; Inoue T; Sugimachi K; Sasazuki T
    Cancer Res; 1992 May; 52(10):2903-6. PubMed ID: 1581907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implications of K-ras mutations in malignant epithelial tumors of the endometrium.
    Mizuuchi H; Nasim S; Kudo R; Silverberg SG; Greenhouse S; Garrett CT
    Cancer Res; 1992 May; 52(10):2777-81. PubMed ID: 1581890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the Kirsten-ras oncogene are common but lack correlation with prognosis and tumor stage in human pancreatic carcinoma.
    Motojima K; Urano T; Nagata Y; Shiku H; Tsunoda T; Kanematsu T
    Am J Gastroenterol; 1991 Dec; 86(12):1784-8. PubMed ID: 1962623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations of the Ki-ras oncogene in carcinoma of the endometrium.
    Caduff RF; Johnston CM; Frank TS
    Am J Pathol; 1995 Jan; 146(1):182-8. PubMed ID: 7856726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection of K-ras mutation from malignant cells in sputum with mutant-allele specific amplification (MASA) method].
    Kimura S; Fukuchi K; Takeda S; Shin S; Saito D; Akamatsu S; Himeji Y; Chen GL; Watanabe H; Takagi Y
    Rinsho Byori; 1995 Jul; 43(7):718-23. PubMed ID: 7674546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of c-Ki-ras oncogene codon 12 point mutations in lung carcinoma, gastric carcinoma and hepatic carcinoma].
    Cui Q; Wang Z; Chen J; Liu T
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1996 Apr; 18(2):95-8. PubMed ID: 9208596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of G-T mutations at codon 12 of c-Ha-ras oncogenes in squamous cell carcinomas of the sinus maxillaris].
    Liu XF
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1992; 27(6):345-7, 382. PubMed ID: 1303668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Low-risk" and "high-risk" HPV-infection and K-ras gene point mutations in human cervical cancer: a study of 31 cases.
    Stenzel A; Semczuk A; Rózyńskal K; Jakowicki J; Wojcierowski J
    Pathol Res Pract; 2001; 197(9):597-603. PubMed ID: 11569923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients.
    Conzelmann M; Linnemann U; Berger MR
    Int J Oncol; 2004 Jun; 24(6):1537-44. PubMed ID: 15138598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genetic alterations and transformations in development and establishment of uterine endometrial carcinomas].
    Inoue M
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Aug; 45(8):751-62. PubMed ID: 8371006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and pathological significance of microsatellite instability in sporadic endometrial carcinoma.
    Caduff RF; Johnston CM; Svoboda-Newman SM; Poy EL; Merajver SD; Frank TS
    Am J Pathol; 1996 May; 148(5):1671-8. PubMed ID: 8623934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity of mutant versus wild-type Ki-ras in primary and metastatic colorectal carcinomas, and association of codon-12 valine with early mortality.
    Al-Mulla F; Going JJ; Sowden ET; Winter A; Pickford IR; Birnie GD
    J Pathol; 1998 Jun; 185(2):130-8. PubMed ID: 9713338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.